|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2010-2-1
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Many countries recommend human papillomavirus (HPV) vaccination in female adolescents at an age when other vaccines are routinely administered. This open, randomized, multicenter study (108464/NCT00426361) evaluated coadministration of HPV-16/18 AS04-adjuvanted vaccine with diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine (dTpa-IPV).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adjuvants, Immunologic,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/Diphtheria-Tetanus-Pertussis Vaccine,
http://linkedlifedata.com/resource/pubmed/chemical/Papillomavirus Vaccines,
http://linkedlifedata.com/resource/pubmed/chemical/Poliovirus Vaccine, Inactivated,
http://linkedlifedata.com/resource/pubmed/chemical/Vaccines, Combined,
http://linkedlifedata.com/resource/pubmed/chemical/human papillomavirus vaccine, L1...
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1879-1972
|
|
pubmed:author |
pubmed-author:BehreUlrichU,
pubmed-author:CarmonaAlfonsoA,
pubmed-author:CatteauGregoryG,
pubmed-author:DescampsDominiqueD,
pubmed-author:DobbelaereKurtK,
pubmed-author:DubinGaryG,
pubmed-author:Garcia-SiciliaJoséJ,
pubmed-author:HPV Vaccine Adolescent Study Investigators Network,
pubmed-author:IturbeEnrique BEB,
pubmed-author:MalkinJean-ElieJE,
pubmed-author:PetersKlausK,
pubmed-author:SchwarzTino FTF,
pubmed-author:ThomasFlorenceF,
pubmed-author:TranPhu MPM
|
|
pubmed:copyrightInfo |
Copyright 2010. Published by Elsevier Inc.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
46
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
142-51
|
|
pubmed:meshHeading |
pubmed-meshheading:20113920-Adjuvants, Immunologic,
pubmed-meshheading:20113920-Adolescent,
pubmed-meshheading:20113920-Antibodies, Viral,
pubmed-meshheading:20113920-Child,
pubmed-meshheading:20113920-Diphtheria-Tetanus-Pertussis Vaccine,
pubmed-meshheading:20113920-Dose-Response Relationship, Drug,
pubmed-meshheading:20113920-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:20113920-Female,
pubmed-meshheading:20113920-Humans,
pubmed-meshheading:20113920-Papillomavirus Infections,
pubmed-meshheading:20113920-Papillomavirus Vaccines,
pubmed-meshheading:20113920-Poliovirus Vaccine, Inactivated,
pubmed-meshheading:20113920-Time Factors,
pubmed-meshheading:20113920-Uterine Cervical Neoplasms,
pubmed-meshheading:20113920-Vaccines, Combined
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine coadministered with combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine to girls and young women.
|
|
pubmed:affiliation |
Hospital Infantil Universitario La Paz, Madrid, Spain. jgarcia-sicilia@telefonica.net
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
